DEVELOPMENT OF A NEW DOSAGE FORM "LOZENGES" FROM THE CONTENTS OF THE SITOPALADI CHURNA BY DIFFERENT METHODS AND ITS COMPARATIVE PHARMACEUTICAL, ANALYTICAL, STABILITY AND PILOT STUDY OF BOTH DOSAGE FORMS ON KASA (DRY COUGH)
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Institute For Ayurved Studies And Research
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To develop the lozenges which is of good consistency with good stability and efficacy.
- 状态
- 尚未招募
- 最后更新
- 去年
概览
简要总结
Ayurveda, the science of life, focuses on both the prevention and cure of diseases by following specific guidelines. Cough is a common symptom experienced by many, often triggered by environmental pollutants like dust, smoke, and chemicals. It is categorized into acute (less than 3 weeks), sub-acute (3-8 weeks), and chronic (more than 8 weeks) forms. In Ayurveda, cough is referred to as "Kasa," a condition caused by imbalances in the Vata and Kapha doshas, affecting the Pranavaha Strotas. It can appear as an independent disease, symptom, or complication. Sitopaladi Churna is a popular Ayurvedic remedy for respiratory issues, known for its anti-tussive, anti-microbial, anti-inflammatory, and anti-expectorant properties. However, its taste and texture can make it difficult to take. To address this, Ayurveda has adapted such formulations into lozenges, which are easier to use, pleasant-tasting, and do not require a vehicle (anupan) for administration, making them more appealing in the modern world.
研究者
DR POOJA
Institute For Ayurved Studies And Research
入排标准
入选标准
- •Patients having classical features of kasa.
- •Patients having cough without sputum.
排除标准
- •Patients below the age of 20 years and above the age of 50 years.
- •Patients suffering from any lower respiratory tract infection like pneumonia, bronchial asthma etc.
- •Patients suffering from tuberculosis, HIV, SLE, respiratory failure, CHF.
- •Patients having Kasa associated with chest injuries, hemoptysis and bronchial carcinoma.
结局指标
主要结局
To develop the lozenges which is of good consistency with good stability and efficacy.
时间窗: The patient will be assessed at 7th and 14th day of the treatment.
次要结局
- To assess whether the lozenges are equally, more or less effective than the sitopaladi churna in the patients of kasa.(The patient will be assessed at 7th & 14th day of the treatment.)